Загрузка...
Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials
Duchenne muscular dystrophy (DMD) is an X-linked human disorder in which absence of the protein dystrophin causes degeneration of skeletal and cardiac muscle. For the sake of treatment development, over and above definitive genetic and cell-based therapies, there is considerable interest in drugs th...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4158345/ https://ncbi.nlm.nih.gov/pubmed/24936034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ilar/ilu011 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|